![Sumant Ramachandra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sumant Ramachandra
Director/Board Member at
LYELL IMMUNOPHARMA, INC.
Net worth: 140 500 $ as of 29/06/2026
Profile
Currently, Sumant Ramachandra is Senior VP, Chief Science & Technology Officer at Baxter International, Inc. Dr. Ramachandra is also on the board of Arog Pharmaceuticals, Inc. Dr. Ramachandra previously held the position of Chief Scientific Officer & SVP-Regulatory Affairs at Hospira, Inc., President-Research & Development at Synta Pharmaceuticals Corp., Senior Vice President, Head-Research & Development at Pfizer Essential Health and Vice President at Schering-Plough Corp. He received an undergraduate degree from Rutgers State University of New Jersey, a doctorate from the University of Medicine & Dentistry of New Jersey and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/06/2026 | 10,000 ( 0.04% ) | 140 500 $ | 29/06/2026 |
Sumant Ramachandra active positions
| Companies | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Director/Board Member | 31/10/2024 |
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Director/Board Member | - |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Chief Executive Officer | 19/04/2025 |
Former positions of Sumant Ramachandra
| Companies | Position | End |
|---|---|---|
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Chief Executive Officer | 30/10/2024 |
| BAXTER INTERNATIONAL INC. | Chief Tech/Sci/R&D Officer | 30/11/2021 |
| HOSPIRA, INC. | Chief Tech/Sci/R&D Officer | 31/12/2014 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Chief Tech/Sci/R&D Officer | 04/05/2013 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 31/12/2007 |
Training of Sumant Ramachandra
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
 Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
- Stock Market
- Insiders
- Sumant Ramachandra
